BioScience Health Innovations (BHIC) Return on Equity (2020 - 2026)

BioScience Health Innovations (BHIC) has 7 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (down 1.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity retreated to 0.0% in Q1 2026 per BHIC's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Equity peaked at 0.11% in Q3 2023 and troughed at 2.73% in Q4 2023.
• A 5-year average of 0.16% and a median of 0.0% in 2024 frame the typical range for Return on Equity.
• The sharpest annual moves came in 2022 and 2024: Return on Equity retreated 10 bps in 2022, then surged 273 bps in 2024.
• A 5-year view of Return on Equity shows it stood at 0.05% in 2022, then slumped by 5453 bps to 2.73% in 2023, then surged by 100 bps to 0.0% in 2024, then soared by 196 bps to 0.0% in 2025, then tumbled by 349 bps to 0.0% in 2026.
• Business Quant data shows BHIC's Return on Equity at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.